Role of Additional Novel Therapies in Myeloproliferative NeoplasmsFISKUS, Warren; GANGULY, Siddhartha; KAMBHAMPATI, Suman et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 959-980 [22 p.]Article

Transient myeloproliferative disorderMOIZ, Bushra; SHAFLQ, Maria.Blood. 2012, Vol 120, Num 24, issn 0006-4971, p. 4672Article

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAGARWAL, Anupriya; BUMM, Thomas G. P; DEININGER, Michael W et al.Blood. 2008, Vol 112, Num 5, pp 1960-1970, issn 0006-4971, 11 p.Article

Myeloproliferative neoplasmsPUBLICOVER, Amy; MEDD, Patrick.Clinical medicine. 2013, Vol 13, Num 2, pp 188-192, issn 1470-2118, 5 p.Article

Myeloproliferative Neoplasm Animal ModelsMULLALLY, Ann; LANE, Steven W; BRUMME, Kristina et al.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, viii-ix, 1065-1081 [18 p.]Article

DNMT3A mutations in myeloproliferative neoplasmsSTEGELMANN, F; BULLINGER, L; SCHLENK, R. F et al.Leukemia. 2011, Vol 25, Num 7, pp 1217-1219, issn 0887-6924, 3 p.Article

Myeloproliferative Disorders in PregnancyHARRISON, Claire N; ROBINSON, Susan E.Hematology/oncology clinics of North America. 2011, Vol 25, Num 2, issn 0889-8588, vii, 261-275 [16 p.]Article

Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid NeoplasmsOGAWA, Seishi; SHIH, Lee-Yung; SUZUKI, Takahiro et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3825-3831, issn 1078-0432, 7 p.Article

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsQUINTAS-CARDAMA, Alfonso; VADDI, Kris; RUPAR, Mark et al.Blood. 2010, Vol 115, Num 15, pp 3109-3117, issn 0006-4971, 9 p.Article

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsSCORE, Joannah; HIDALGO-CURTIS, Claire; CHASE, Andrew et al.Blood. 2012, Vol 119, Num 5, pp 1208-1213, issn 0006-4971, 6 p.Article

Competing cell clones in myeloproliferative neoplasmAL-KALI, Aref; VERSTOVSEK, Srdan; KANTARJIAN, Hagop et al.Blood. 2010, Vol 116, Num 23, pp 5074-5075, issn 0006-4971, 2 p.Article

Myeloproliferative Disorders and the Hyperviscosity SyndromeADAMS, Bruce D; BAKER, Russell; LOPEZ, J. Abraham et al.Hematology/oncology clinics of North America. 2010, Vol 24, Num 3, issn 0889-8588, viii, 585-602 [28 p.]Article

Myeloproliferative Disorders and the Hyperviscosity SyndromeADAMS, Bruce D; BAKER, Russell; LOPEZ, J. Abraham et al.Emergency medicine clinics of North America. 2009, Vol 27, Num 3, issn 0733-8627, vi, 459-476 [19 p.]Article

RECONNAITRE, CLASSER ET TRAITER LES SYNDROMES MYÉLOPROLIFÉRATIFS BCR-ABL NÉGATIFSKNOOPS, L.Louvain médical. 2008, Vol 127, Num 7, pp 247-255, issn 0024-6956, 9 p.Conference Paper

Polyglobulie de Vaquez et mutation JAK-2 chez l'enfant : à propos d'une observation = Polycythemia vera and JAK-2 mutation in childhood : a case reportBRACONNIER, O; MONPOUX, F; AFFANETTI, M et al.Archives de pédiatrie (Paris). 2007, Vol 14, Num 10, pp 1202-1205, issn 0929-693X, 4 p.Article

Prise en charge diagnostique et thérapeutique d'un patient porteur d'une thrombocytose = Investigation and management of patients presenting with thrombocytosisCHEMINANT, M; DELARUE, R.La Revue de médecine interne (Paris). 2013, Vol 34, Num 8, pp 465-471, issn 0248-8663, 7 p.Article

Deep Molecular Response in Chronic Myeloid Leukemia: The New Goal of Therapy?MAHON, François-Xavier; ETIENNE, Gabriel.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 310-322, issn 1078-0432, 13 p.Article

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic ExperienceTEFFERI, Ayalew; LASHO, Terra L; PARDANANI, Animesh et al.Mayo Clinic proceedings. 2012, Vol 87, Num 1, pp 25-33, issn 0025-6196, 9 p.Article

Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies RevisitedJEREZ, Andres; GONDEK, Lukasz P; MCDEVITT, Michael A et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1343-1349, issn 0732-183X, 7 p.Article

Unique features of primary myelofibrosis in ChineseZEFENG XU; PETER GALE, Robert; YUE ZHANG et al.Blood. 2012, Vol 119, Num 11, pp 2469-2473, issn 0006-4971, 5 p.Article

Acquired Uniparental Disomy in Myeloproliferative NeoplasmsSCORE, Joannah; CROSS, Nicholas C. P.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 981-991 [12 p.]Article

Megakaryocyte dysplasia in primary myelofibrosisBAIN, Barbara J.American journal of hematology. 2010, Vol 85, Num 11, issn 0361-8609, p. 886Article

Blast phase of essential thrombocythemia: A single center studyPASSAMONTI, Francesco; RUMI, Elisa; LAZZARINO, Mario et al.American journal of hematology. 2009, Vol 84, Num 10, pp 641-644, issn 0361-8609, 4 p.Article

Familial Chronic Myeloproliferative Disorders : Clinical Phenotype and Evidence of Disease AnticipationRUMI, Elisa; PASSAMONTI, Francesco; CAZZOLA, Mario et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5630-5635, issn 0732-183X, 6 p.Article

Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative NeoplasmsNISCHAL, Sangeeta; BHATTACHARYYA, Sanchari; PARDANANI, Animesh et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 3, pp 1076-1085, issn 0008-5472, 10 p.Article